FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma.

Florian Puls, Jakob Hofvander, Linda Magnusson, Jenny Nilsson, Elaine Haywood, Vaiyapuri P Sumathi, D Chas Mangham, Lars-Gunnar Kindblom, Fredrik Mertens

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

35 Citeringar (SciVal)

Sammanfattning

Calcifying aponeurotic fibroma (CAF) is a soft tissue neoplasm with a predilection for the hands and feet in children and adolescents. Its molecular basis is unknown. We used chromosome banding analysis, fluorescence in situ hybridization (FISH), mRNA sequencing (RNA-seq), RT-PCR and immunohistochemistry to characterize a series of CAFs. An insertion ins(2;4)(q35;q25q?) was identified in the index case. Fusion of the FN1 and EGF genes, mapping to the breakpoint regions on chromosomes 2 and 4, respectively, were detected by RNA-seq and confirmed by RT-PCR in the index case and two additional cases. FISH on five additional tumour identified FN1-EGF fusions in all cases. CAFs analysed by RT-PCR showed that FN1 exon 23, 27 or 42 were fused to EGF exon 17 or 19. High level expression of the entire FN1 gene in CAF suggests that strong FN1 promoter activity drives inappropriate expression of the biologically active portion of EGF which was detected immunohistochemically in 8/9 cases. The FN1-EGF fusion, which has not been observed in any other neoplasm, appears to be the main driver mutation in CAF. Although further functional studies are required to understand the exact pathogenesis of CAF, the composition of the chimera suggests an autocrine/paracrine mechanism of transformation.
Originalspråkengelska
Sidor (från-till)502-507
TidskriftJournal of Pathology
Volym238
Nummer4
Tidigt onlinedatum2015 dec. 22
DOI
StatusPublished - 2016

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi
  • Medicinsk genetik

Fingeravtryck

Utforska forskningsämnen för ”FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här